---
title: "Top 10 HK Stock Losers (4.10)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/282312544.md"
description: "ZHONGMIAO(01471) fell 33.38%, with a trading turnover 3.6 Million HKD, and a year-to-date rose 78%. BAO PHARMA-B(02659) fell 13.43%, with a trading turnover 163.4 Million HKD, and a year-to-date rose 28.4%. GUOXIA TECH(02655) fell 11.08%, with a trading turnover 110.4 Million HKD, and a year-to-date rose 29.7%."
datetime: "2026-04-10T08:30:51.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/282312544.md)
  - [en](https://longbridge.com/en/news/282312544.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/282312544.md)
---

# Top 10 HK Stock Losers (4.10)

Hang Seng Index has rose 0.55%, with a year-to-date rose 1%; Hang Seng TECH Index has rose 0.8%, with a year-to-date fell 11.9%.

ZHONGMIAO(01471) fell 33.38%, with a trading turnover 3.6 Million HKD, and a year-to-date rose 78%.

BAO PHARMA-B(02659) fell 13.43%, with a trading turnover 163.4 Million HKD, and a year-to-date rose 28.4%.

GUOXIA TECH(02655) fell 11.08%, with a trading turnover 110.4 Million HKD, and a year-to-date rose 29.7%.

### Related Stocks

- [01471.HK](https://longbridge.com/en/quote/01471.HK.md)
- [02659.HK](https://longbridge.com/en/quote/02659.HK.md)
- [02655.HK](https://longbridge.com/en/quote/02655.HK.md)
- [01133.HK](https://longbridge.com/en/quote/01133.HK.md)
- [09878.HK](https://longbridge.com/en/quote/09878.HK.md)
- [06869.HK](https://longbridge.com/en/quote/06869.HK.md)
- [03881.HK](https://longbridge.com/en/quote/03881.HK.md)
- [02656.HK](https://longbridge.com/en/quote/02656.HK.md)
- [08279.HK](https://longbridge.com/en/quote/08279.HK.md)
- [06687.HK](https://longbridge.com/en/quote/06687.HK.md)

## Related News & Research

- [Shanghai Bao Pharma Wins NMPA Nod for Recombinant Human Hyaluronidase Injection](https://longbridge.com/en/news/281971171.md)
- [Huitongda Enters ‘New Phase’ as Profit Margins Hit Record Highs in 2025](https://longbridge.com/en/news/281061207.md)
- [Shanghai Bao Completes Phase III Follow-Up for Breakthrough Kidney Transplant Drug KJ103](https://longbridge.com/en/news/280422540.md)
- [JST Group Corporation Limited (6687) Gets a Buy from CICC](https://longbridge.com/en/news/273032955.md)
- [160 Health Controlling Shareholders Extend Lock-Up on 30.59% Stake](https://longbridge.com/en/news/278997162.md)